On Sept. 30, 2026, Thewaico, a bioprocess innovation company, today emerged from stealth with an integrated bioreactor and…
On Sept. 28, 2026, AN2 Therapeutics, a clinical stage pharmaceutical company focused on the discovery and development of…
On Sept. 25, 2026, the US Food and Drug Administration announced approval of AbbVie’s treatment for Parkinson’s disease…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 8, 2026, Google DeepMind released the AlphaGenome Atlas: a platform containing predictions for the effects of…
On Sept. 3, Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved ZANVASTRO™ (zilganersen)…
On Sept. 1, 2026, Vertex Pharmaceuticals announced the successful completion of the acquisition of Crinetics Pharmaceuticals, a global…
On Aug. 31, 2026, the White House announced agreements with nine- mid-sized pharmaceutical manufacturers to lower prescription drug…
On Aug. 28, 2026, scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub,…
On Aug. 25, 2026, Haisco Pharmaceutical Group announced on that it has entered into an exclusive licensing agreement…
On Aug. 18, 2026, BioMarin Pharmaceutical announced a definitive agreement to acquire Alesta Therapeutics to gain Alesta’s lead…
On Aug. 10, 2026, Bristol Myers Squibb (BMS) announced the selection of Houston, Texas, as the site for…
On Aug. 10, 2026, the Institute for Health Metrics and Evaluation (IHME), an independent research organization at the…
On Jul. 24, 2026, U.S. Food and Drug Administration (FDA) approved Tylenol with Naproxen (acetaminophen 325 mg/naproxen sodium…
On Jul. 24, 2026, Otsuka Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted approval…
On Jul. 20, 2026, Bristol Myers Squibb announced it will expand its compute infrastructure to deploy an NVIDIA…
On Jul. 19, 2026, Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100%…
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
On Jun. 17, 2026, Biogen and RayThera, a private biotechnology company focused on discovering and developing small molecule…
On Jun. 16, 2026, Protillion Biosciences, a leader in lab-in-the-loop AI drug design,announced the signing of a multi-target…
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…
On Jun. 8, 2026, the Wellcome Sanger Institute, Google.org, and Google DeepMind announced they are partnering up to…
On Jun. 8, 2026, Johnson & Johnson announced it has entered into a definitive agreement to acquire Firefly…
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
On May 26, 2026, Eli Lilly announced agreements to acquire three companies, Curevo, LimmaTech Biologics, and Vaccine Company,…
On May 18, 2026, scientists from the University of York and University of Copenhagen announced they have uncovered…
On May 7, 2026, Angelini Pharma and Catalyst Pharmaceuticals, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and…
On May 6, 2026, Eli Lilly announced an additional $4.5 billion investment across two of its three Lebanon…